Recent studies have indicated that antimetabolites such as thioguanine and 6-mercaptopurine may be effective in a variety of conditions that may be caused by the production of abnormal gamma globulins ...

The FDA approved the enzyme replacement therapy Adzynma for the prophylactic or on-demand treatment of adults and pediatric patients with congenital thrombotic thrombocytopenic purpura, a rare blood ...

Please provide your email address to receive an email when new articles are posted on . A treatment involving broadband light improved the clinical appearance of senile purpura and prevented future ...

Recognition of immune thrombocytopenic purpura is increasing because of the increasing frequency of routine blood counts that reveal unexpected thrombocytopenia. For patients who may have immune ...

An expert discusses treatment strategies for immune thrombocytopenic purpura (ITP), emphasizing individualized decisions based on platelet count, bleeding symptoms, and comorbidities, with options ...

cTTP is an Ultra-rare Blood Clotting Disorder Associated with Life-Threatening Acute Events and Debilitating Chronic Symptoms Takeda Continues 70-plus Year Legacy of Driving Innovation for the Rare ...

FDA Approves Rhophylac(R) for the Treatment of Immune Thrombocytopenic Purpura KING OF PRUSSIA, Pa., April 2 -- CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted ...

My patient is a 45-year-old Middle Eastern man who presented with acute onset of lower-extremity (legs and buttocks), palpable, non-blanching purpura 1 day after he had taken several Tylenol and ...

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE: 4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has accepted Takeda’s Biologics License Application (BLA) ...

X. Long Zheng, MD, PhD, gives an overview on acquired thrombotic thrombocytopenic purpura including prevalence and the typical patient presentation. X. Long Zheng, MD, PhD, details the typical ...

Use of oncology drugs in Japan compared to France, Germany, Italy, Spain, Sweden, the United Kingdom, and the United States: A comparison based on data from 1999 to 2009. This is an ASCO Meeting ...

Is there any new information available regarding the treatment of Henoch-Schönlein purpura (HSP)? —Norma L. Sneed, MD, Checotah, Okla. HSP is a form of systemic small-vessel vasculitis characterized ...